Symbol="PPBT"
AssetType="Common Stock"
Name="Purple Biotech"
Description="Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United States. The company is headquartered in Rehovot, Israel."
CIK="1614744"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="ONE AZRIELI CENTER, ROUND TOWER, 132 MENACHEM BEGIN ROAD, TEL AVIV, IL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="25107300"
EBITDA="-20215000"
PERatio="None"
PEGRatio="None"
BookValue="2.36"
DividendPerShare="0"
DividendYield="0"
EPS="-0.97"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.212"
ReturnOnEquityTTM="-0.367"
RevenueTTM="0"
GrossProfitTTM="-120000"
DilutedEPSTTM="-0.97"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="8.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="58.08"
PriceToBookRatio="0.568"
EVToRevenue="33.08"
EVToEBITDA="-0.072"
Beta="1.374"
num_52WeekHigh="2.8"
num_52WeekLow="1.02"
num_50DayMovingAverage="1.516"
num_200DayMovingAverage="1.798"
SharesOutstanding="21005000"
DividendDate="2020-08-21"
ExDividendDate="None"
symbol="PPBT"
open="1.13"
high="1.15"
low="1.02"
price="1.09"
volume="137865.00"
latest_trading_day="2023-07-31"
previous_close="1.11"
change="-0.02"
change_percent="-1.8018%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="62"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="38"
Volume_recent_avg="59952"
Change_recent_avg="-0.02"
Delta_recent_avg="0.11"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-1.17"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="38"
Aroon_momentum_negative="62"
image_negative_thumbnail_id_1="1110"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0143.jpeg"
image_negative_thumbnail_id_2="1164"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0198.jpeg"
image_neutral_thumbnail_id_1="575"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0024.jpeg"
image_neutral_thumbnail_id_2="588"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_positive_thumbnail_id_1="654"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0054.jpeg"
image_positive_thumbnail_id_2="656"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0052.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
